SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C

CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER

1. Date of Report (Date of earliest event reported)

Sep 29, 2025

2. SEC Identification Number

CS202052294

3. BIR Tax Identification No.

502-228-971-000

4. Exact name of issuer as specified in its charter

MREIT, Inc.

5. Province, country or other jurisdiction of incorporation

Metro Manila, Philippines

6. Industry Classification Code(SEC Use Only)

7. Address of principal office

18th Floor, Alliance Global Tower, 36th Street corner 11th Avenue, Uptown Bonifacio, Taguig City, Philippines Postal Code 1634

8. Issuer's telephone number, including area code

(632) 8894-6300/6400

9. Former name or former address, if changed since last report

N/A

10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA

Title of Each Class	Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common Shares	3,721,983,381

11. Indicate the item numbers reported herein

Item 9

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

MREIT, Inc.MREIT

PSE Disclosure Form 4-3 - Amendments to Articles of Incorporation References: SRC Rule 17 (SEC Form 17-C) and
Section 4.4 of the Revised Disclosure Rules

Subject of the Disclosure
Amendment of Article VII of the Amended Articles of Incorporation
Background/Description of the Disclosure
On 12 August 2025, the Board of Directors approved the amendment of Article VII of the Amended Articles of Incorporation of MREIT, Inc, which was subsequently ratified by the stockholders representing at least two-thirds (2/3) of the outstanding capital stock during the Annual Stockholders’ Meeting held on 29 September 2025.

Date of Approval by Board of Directors	Aug 12, 2025
Date of Approval by Stockholders	Sep 29, 2025
Other Relevant Regulatory Agency, if applicable	N/A
Date of Approval by Relevant Regulatory Agency, if applicable	N/A
Date of Approval by Securities and Exchange Commission	TBA
Date of Receipt of SEC approval	TBA

Amendment(s)

Article No.	From	To
Seventh	The authorized capital stock of the corporation is Five Billion Pesos (Php5,000,000,000.00) in lawful money of the Philippines, divided into FIVE BILLION (5,000,000,000) common voting shares with par value of ONE PESO (Php1.00) per share. No stockholders of any class shall be entitled to any pre-emptive rights to purchase, subscribe for, or receive any part of the shares of the Corporation, whether issued from its unissued capital, increase in its authorized capital or its treasury stock.	The authorized capital stock of the corporation is Eight Billion Pesos (Php8,000,000,000.00) in lawful money of the Philippines, divided into EIGHT BILLION (8,000,000,000) common voting shares with par value of ONE PESO (Php1.00) per share. No stockholders of any class shall be entitled to any pre-emptive rights to purchase, subscribe for, or receive any part of the shares of the Corporation, whether issued from its unissued capital, increase in its authorized capital or its treasury stock.

Rationale for the amendment(s)
The proposed amendment is being suggested to support MREIT's growth by facilitating the infusion of additional assets under management.

The timetable for the effectivity of the amendment(s)

Expected date of filing the amendments to the Articles of Incorporation with the SEC	TBA
Expected date of SEC approval of the Amended Articles of Incorporation	TBA

Effect(s) of the amendment(s) to the business, operations and/or capital structure of the Issuer, if any
The increase in ACS will enable MREIT to expand its assets under management through asset infusions and other permissible investments in accordance with the REIT Law.
Other Relevant Information
The disclosure is amended to reflect the stockholders’ approval of the foregoing amendment to the Seventh Article of the Corporation’s Amended Articles of Incorporation.